taxonomy (9)
protein (134)
source (20)
structure (26)
composition (1)
disease (9)
reference (32)
site (197)
peptide (189)
- Homo sapiens (Human)
- Bos taurus (Bovine)
- Canis lupus familiaris (Dog)
- Mus musculus (House mouse)
- Ovis aries (Sheep)
- Gallus gallus (Chicken)
- Torpedo californica (Pacific electric ray)
- Friend murine leukemia virus (F-mulv)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- 4F2 cell-surface antigen heavy chain / Homo sapiens P08195
- ADAM DEC1 / Homo sapiens O15204
- Adenosine deaminase 2 / Homo sapiens Q9NZK5
- Adhesion G protein-coupled receptor F5 / Homo sapiens Q8IZF2
- Alpha-1-acid glycoprotein 1 / Homo sapiens P02763
- Alpha-1-acid glycoprotein 2 / Homo sapiens P19652
- Alpha-1-antichymotrypsin / Homo sapiens P01011
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-2-HS-glycoprotein / Homo sapiens P02765
- Aminopeptidase n / Homo sapiens P15144
- Angiotensin-converting enzyme / Homo sapiens P12821
- Angiotensin-converting enzyme 2 / Homo sapiens Q9BYF1
- Angiotensinogen / Homo sapiens P01019
- Apolipoprotein (a) / Homo sapiens P08519
- Apolipoprotein B-100 / Homo sapiens P04114
- Apolipoprotein D / Homo sapiens P05090
- Attractin / Homo sapiens O75882
- Beta-2-glycoprotein 1 / Homo sapiens P02749
- Biglycan / Homo sapiens P21810
- Butyrophilin subfamily 1 member A1 / Homo sapiens Q13410
- Carboxypeptidase N subunit 2 / Homo sapiens P22792
- Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens P06731
- Catalase / Homo sapiens P04040
- CD109 antigen / Homo sapiens Q6YHK3
- CD16A-NK08-V/F genotype / Homo sapiens P08637
- CD16A-NK09-V/F genotype / Homo sapiens P08637
- CD16A-NK11-F/F genotype / Homo sapiens P08637
- CD16A-NK12-V/F genotype / Homo sapiens P08637
- CD16A-NK13-V/F genotype / Homo sapiens P08637
- CD276 antigen / Homo sapiens Q5ZPR3
- CD44 antigen / Homo sapiens P16070
- CD59 glycoprotein / Homo sapiens P13987
- Ceruloplasmin / Homo sapiens P00450
- Cholesteryl ester transfer protein / Homo sapiens P11597
- Clusterin / Homo sapiens P10909
- Coagulation factor VIII / Homo sapiens P00451
- Coagulation factor x / Homo sapiens P00742
- Collagen alpha-2(VI) chain / Homo sapiens P12110
- Collagen alpha-3(VI) chain / Homo sapiens P12111
- Complement c1r subcomponent / Homo sapiens P00736
- Complement factor h / Homo sapiens P08603
- Contactin-4 / Homo sapiens Q8IWV2
- Corticosteroid-binding globulin / Homo sapiens P08185
- Decorin / Homo sapiens P07585
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens P78536
- Ecto-ADP-ribosyltransferase 4 / Homo sapiens Q93070
- Endoplasmic reticulum aminopeptidase 2 / Homo sapiens Q6P179
- Endothelial cell-selective adhesion molecule / Homo sapiens Q96AP7
- Ephrin-B2 / Homo sapiens P52799
- Epidermal growth factor receptor / Homo sapiens P00533
- Epithelial cell adhesion molecule / Homo sapiens P16422
- Fibrillin-1 / Homo sapiens P35555
- Fibroblast growth factor receptor 1 / Homo sapiens P11362
- Fibroleukin / Homo sapiens Q14314
- Fibromodulin / Homo sapiens Q06828
- Fibronectin / Homo sapiens P02751
- Filamin-B / Homo sapiens O75369
- Folate receptor alpha / Homo sapiens P15328
- Galectin-3-binding protein / Homo sapiens Q08380
- Gamma-glutamyltransferase light chain 1 / Homo sapiens Q9BX51
- Gamma-glutamyltransferase light chain 2 / Homo sapiens Q14390
- Gamma-glutamyltranspeptidase 1 / Homo sapiens P19440
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- Hepatocyte growth factor receptor / Homo sapiens P08581
- Immunoglobulin heavy constant alpha 1 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 1 - heavy chain 1 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 1 - heavy chain 2 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 2 / Homo sapiens P01877
- Immunoglobulin heavy constant epsilon - heavy chain 1 / Homo sapiens P01854
- Immunoglobulin heavy constant epsilon - heavy chain 2 / Homo sapiens P01854
- Immunoglobulin heavy constant gamma 4 / Homo sapiens P01861
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Integrin alpha-2 / Homo sapiens P17301
- Integrin alpha-X / Homo sapiens P20702
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens Q14624
- Interferon alpha/beta receptor 2 / Homo sapiens P48551
- Interleukin-6 receptor subunit beta / Homo sapiens P40189
- Kinesin-1 heavy chain / Homo sapiens P33176
- Kininogen-1 / Homo sapiens P01042
- Lactotransferrin / Homo sapiens P02788
- Laminin subunit alpha-2 / Homo sapiens P24043
- Laminin subunit alpha-4 / Homo sapiens Q16363
- Laminin subunit gamma-1 / Homo sapiens P11047
- Leucine-rich alpha-2-glycoprotein / Homo sapiens P02750
- Low-density lipoprotein receptor-related protein 2 / Homo sapiens P98164
- Lumican / Homo sapiens P51884
- Lymphatic vessel endothelial hyaluronic acid receptor 1 / Homo sapiens Q9Y5Y7
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Maltase-glucoamylase, intestinal / Homo sapiens O43451
- Microfibril-associated glycoprotein 4 / Homo sapiens P55083
- Mimecan / Homo sapiens P20774
- Multimerin-1 / Homo sapiens Q13201
- Myeloperoxidase / Homo sapiens P05164
- Neogenin / Homo sapiens Q92859
- Neuron navigator 2 / Homo sapiens Q8IVL1
- Neuronal cell adhesion molecule / Homo sapiens Q92823
- Plasma serine protease inhibitor / Homo sapiens P05154
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Prolactin-inducible protein / Homo sapiens P12273
- Prolargin / Homo sapiens P51888
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens Q07954
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Protein AMBP / Homo sapiens P02760
- Ras-specific guanine nucleotide-releasing factor 1 / Homo sapiens Q13972
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens P08575
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens Q15262
- Receptor-type tyrosine-protein phosphatase mu / Homo sapiens P28827
- RNA-binding protein 44 / Homo sapiens Q6ZP01
- Scavenger receptor cysteine-rich type 1 protein M130 / Homo sapiens Q86VB7
- Secretogranin-3 / Homo sapiens Q8WXD2
- Semaphorin-3F / Homo sapiens Q13275
- Semaphorin-4D / Homo sapiens Q92854
- Serotransferrin / Homo sapiens P02787
- Sparc / Homo sapiens P09486
- Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 / Homo sapiens Q4LDE5
- Target of Nesh-SH3 / Homo sapiens Q7Z7G0
- Thrombospondin-1 / Homo sapiens P07996
- Transmembrane glycoprotein NMB / Homo sapiens Q14956
- Transmembrane protein 87A / Homo sapiens Q8NBN3
- Trem-like transcript 2 protein / Homo sapiens Q5T2D2
- Uromodulin / Homo sapiens P07911
- Vitronectin / Homo sapiens P04004
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Alpha-1-acid glycoprotein / Bos taurus Q3SZR3
- Alpha-2-hs-glycoprotein / Bos taurus P12763
- Alpha-1-acid glycoprotein / Canis lupus familiaris F6Y713
- Zona pellucida sperm-binding protein matrix / Mus musculus P20239 Q62005 P10761
- Alpha-1-acid glycoprotein / Ovis aries W5P7S6
- Acetylcholine receptor protein / Torpedo californica P02714 P02718 P02712 P02710
- Envelope glycoprotein / Friend murine leukemia virus P03395
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Ascitic fluid (UBERON_0007795)
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977) Mature NK T cell (CL_0000814)
- Blood Serum (UBERON_0001977)
- Bone Marrow (UBERON_0002371)
- Colon (UBERON_0001155)
- Electric Organ (UBERON_0006869)
- Liver (UBERON_0002107)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Urine (UBERON_0001088)
- Zona Pellucida (UBERON_0000086)
- Eveline (CVCL_A1LI)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- Jurkat (CVCL_0065)
- LS174T (CVCL_1384)
- Adipocytes (CL_0000136)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
Source
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)[Gal(?1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(?1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)Man(a1-3)[Gal(b1-4)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(?1-?) + NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 2772
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 9470
- N-Linked / Complex / Structure 9546
- N-Linked / Complex / Structure 9565
- N-Linked / Complex / Structure 9636
- N-Linked / Complex / Structure 10039
- N-Linked / Complex / Structure 10436
- N-Linked / Complex / Structure 10655
- N-Linked / Complex / Structure 10700
- N-Linked / Complex / Structure 10929
- N-Linked / Complex / Structure 11250
Reported structure
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
Composition
- Cancer, breast (DOID:1612)
- Colon adenocarcinoma (DOID:234)
- Control/Healthy
- COVID-19 (DOID:0080600)
- Familial hepatic adenoma (DOID:111366)
- Mixed phenotype acute leukemia (DOID:9953)
- Multiple myeloma (DOID:9538)
- Prostate cancer (DOID:10283)
- T-cell childhood acute lymphocytic leukemia (DOID:0080145)
Disease
- Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. (2021 - Oliveira T, Zhang M, Joo EJ, Abdel-Azim H, Chen CW, Yang L, Chou CH, Qin X, Chen J, Alagesan K, Almeida A, Jacob F, Packer NH, von Itzstein M, Heisterkamp N, Kolarich D) / Status : Reviewed
- Carcinoembryonic antigen glycosylation (2021 - Kolarich D) / Status : Reviewed
- Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis (2021 - Luisa Sturiale, Marie-Cécile Nassogne, Angelo Palmigiano, Angela Messina, Immacolata Speciale, Rosangela Artuso, Gaetano Bertino, Nicole Revencu, Xavier Stephénne, Cristina De Castro, Gert Matthijs, Rita Barone, Jaak Jaeken, Domenico Garozzo) / Status : Reviewed
- Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures. (2021 - Suzuki N, Abe T, Hanzawa K, Natsuka S) / Status : Reviewed
- Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis. (2020 - Katherine Wongtrakul-Kish, Benjamin R Herbert, Nicolle H Packer) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells. (2019 - Martina Pirro, Esmee Schoof, Sandra J. van Vliet, Yoann Rombouts, Alexandre Stella, Arnoud de Ru, Yassene Mohammed, Manfred Wuhrer, Peter A. van Veelen, Paul J. Hensbergen) / Status : Reviewed
- A novel, ultrasensitive approach for quantitative carbohydrate composition and linkage analysis using LC-ESI ion trap tandem mass spectrometry (2019 - Kathirvel Alagesan, Daniel Varon Silva, Peter H Seeberger, Daniel Kolarich) / Status : Reviewed
- Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability. (2019 - Patel KR, Nott JD, Barb AW) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- In-depth analysis of site-specific N-glycosylation in vitronectin from human plasma by tandem mass spectrometry with immunoprecipitation (2014 - Hwang H, Lee JY, Lee HK, Park GW, Jeong HK, Moon MH, Kim JY, Yoo JS.) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
- Site-specific glycoprofiling of N-linked glycopeptides using MALDI-TOF MS: strong correlation between signal strength and glycoform quantities. (2009 - Thaysen-Andersen M, Mysling S, Højrup P) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Structural analysis of murine zona pellucida glycans. Evidence for the expression of core 2-type O-glycans and the Sd(a) antigen. (2000 - Easton RL, Patankar MS, Lattanzio FA, Leaven TH, Morris HR, Clark GF, Dell A) / Status : Reviewed
- Structural determination of N-linked carbohydrates by matrix-assisted laser desorption/ionization-mass spectrometry following enzymatic release within sodium dodecyl sulfate-polyacrylamide electrophoresis gels: application to species-specific glycosylation of alpha1-acid glycoprotein. (1998 - Kuster B, Hunter A, Wheeler S, Dwek R, Harvey D) / Status : Reviewed
- Two-dimensional chromatography in the analysis of complex glycans from transferrin. (1998 - Charlwood J, Birrell H, Tolson D, Camilleri P) / Status : Reviewed
- Identification of the oligosaccharide structures of human coagulation factor X activation peptide at each glycosylation site. (1995 - Nakagawa H, Takahashi N, Fujikawa K, Kawamura Y, Iino M, Takeya H, Ogawa H, Suzuki K) / Status : Reviewed
- Reducing-end modification of N-linked oligosaccharides with tyrosine. (1994 - Tamura T, Wadhwa M, Rice K) / Status : Reviewed
- Detailed structural analysis of asparagine-linked oligosaccharides of the nicotinic acetylcholine receptor from Torpedo californica. (1992 - Shoji H, Takahashi N, Nomoto H, Ishikawa M, Shimada I, Arata Y, Hayashi K) / Status : Reviewed
- Oligosaccharides at individual glycosylation sites in glycoprotein 71 of Friend murine leukemia virus. (1990 - Geyer R, Dabrowski J, Dabrowski U, Linder D, Schlter M, Schott H, Stirm S) / Status : Reviewed
- The asparagine-linked oligosaccharides on bovine fetuin. Structural analysis of N-glycanase-released oligosaccharides by 500-megahertz 1H NMR spectroscopy. (1988 - Green E, Adelt G, Baenziger J, Wilson S, Van Halbeek H) / Status : Reviewed
Reference
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- ADAM DEC1 / Homo sapiens
- Adenosine deaminase 2 / Homo sapiens
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Aminopeptidase n / Homo sapiens
- Angiotensin-converting enzyme / Homo sapiens
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- Angiotensinogen / Homo sapiens
- Apolipoprotein (a) / Homo sapiens
- Apolipoprotein B-100 / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Attractin / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Butyrophilin subfamily 1 member A1 / Homo sapiens
- Carboxypeptidase N subunit 2 / Homo sapiens
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
- Catalase / Homo sapiens
- CD109 antigen / Homo sapiens
- CD16A-NK08-V/F genotype / Homo sapiens
- CD16A-NK09-V/F genotype / Homo sapiens
- CD16A-NK11-F/F genotype / Homo sapiens
- CD16A-NK12-V/F genotype / Homo sapiens
- CD16A-NK13-V/F genotype / Homo sapiens
- CD276 antigen / Homo sapiens
- CD44 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Cholesteryl ester transfer protein / Homo sapiens
- Clusterin / Homo sapiens
- Coagulation factor VIII / Homo sapiens
- Coagulation factor x / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement c1r subcomponent / Homo sapiens
- Complement factor h / Homo sapiens
- Contactin-4 / Homo sapiens
- Corticosteroid-binding globulin / Homo sapiens
- Decorin / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens
- Ecto-ADP-ribosyltransferase 4 / Homo sapiens
- Endoplasmic reticulum aminopeptidase 2 / Homo sapiens
- Endothelial cell-selective adhesion molecule / Homo sapiens
- Ephrin-B2 / Homo sapiens
- Epidermal growth factor receptor / Homo sapiens
- Epithelial cell adhesion molecule / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibroblast growth factor receptor 1 / Homo sapiens
- Fibroleukin / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Filamin-B / Homo sapiens
- Folate receptor alpha / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Gamma-glutamyltransferase light chain 1 / Homo sapiens
- Gamma-glutamyltransferase light chain 2 / Homo sapiens
- Gamma-glutamyltranspeptidase 1 / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Hepatocyte growth factor receptor / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
-
Immunoglobulin heavy constant alpha 1 - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant alpha 1 - heavy chain 2 / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
-
Immunoglobulin heavy constant epsilon - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 2 / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Integrin alpha-2 / Homo sapiens
- Integrin alpha-X / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Interferon alpha/beta receptor 2 / Homo sapiens
- Interleukin-6 receptor subunit beta / Homo sapiens
- Kinesin-1 heavy chain / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-2 / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Low-density lipoprotein receptor-related protein 2 / Homo sapiens
- Lumican / Homo sapiens
- Lymphatic vessel endothelial hyaluronic acid receptor 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Maltase-glucoamylase, intestinal / Homo sapiens
- Microfibril-associated glycoprotein 4 / Homo sapiens
- Mimecan / Homo sapiens
- Multimerin-1 / Homo sapiens
- Myeloperoxidase / Homo sapiens
- Neogenin / Homo sapiens
- Neuron navigator 2 / Homo sapiens
- Neuronal cell adhesion molecule / Homo sapiens
- Plasma serine protease inhibitor / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Protein AMBP / Homo sapiens
- Ras-specific guanine nucleotide-releasing factor 1 / Homo sapiens
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Receptor-type tyrosine-protein phosphatase mu / Homo sapiens
- RNA-binding protein 44 / Homo sapiens
- Scavenger receptor cysteine-rich type 1 protein M130 / Homo sapiens
- Secretogranin-3 / Homo sapiens
- Semaphorin-3F / Homo sapiens
- Semaphorin-4D / Homo sapiens
- Serotransferrin / Homo sapiens
- Sparc / Homo sapiens
- Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 / Homo sapiens
- Target of Nesh-SH3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Transmembrane glycoprotein NMB / Homo sapiens
- Transmembrane protein 87A / Homo sapiens
- Trem-like transcript 2 protein / Homo sapiens
- Uromodulin / Homo sapiens
- Vitronectin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
-
Alpha-1-acid glycoprotein / Bos taurus
- Undefined site
- Alpha-2-hs-glycoprotein / Bos taurus
-
Alpha-1-acid glycoprotein / Canis lupus familiaris
- Undefined site
-
Zona pellucida sperm-binding protein matrix / Mus musculus
- Undefined site
-
Alpha-1-acid glycoprotein / Ovis aries
- Undefined site
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
- Envelope glycoprotein / Friend murine leukemia virus
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- LVPVPITNATLDR (13aa)
- LVPVPITNATLDQITGK (17aa)
- SIVLEPIYWNSSNSK (15aa)
- TAVNCSSDFDACLITK (16aa)
- HLVIHNESTCEQLAK (15aa)
- WQMNFTVR (8aa)
- ANQQLNFTEAK (11aa)
- KANQQINFTEAK (12aa)
- ATGTAHFFNFLLNTTDYR (18aa)
- AFNSTLPTMAQMEK (14aa)
- NTTIFLK (7aa)
- FHNESLISSQASSY (14aa)
- P08637 Asn-63     CD16A-NK13-V/F genotype / Homo sapiens
- P08637 Asn-63     CD16A-NK12-V/F genotype / Homo sapiens
- P08637 Asn-63     CD16A-NK08-V/F genotype / Homo sapiens
- P08637 Asn-63     CD16A-NK09-V/F genotype / Homo sapiens
- P08637 Asn-63     CD16A-NK11-F/F genotype / Homo sapiens
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- CIQANYSLMENGK (13aa)
- CIQANYSIMENGK (13aa)
- RALGFENATQALGRA (15aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- SVQEIQATFFYFTPNK (16aa)
- AEMNGSK (7aa)
- SVVAPATDGGLNLTSTFLRK (20aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- NNATVHEQVGGPSLTSDLQAQSK (23aa)
- KKKEDALNETRE (12aa)
- VVNITMVALK (10aa)
- QNQCFYNSSYLNVQR (15aa)
- QDQCIYNTTYINVQR (15aa)
- QDQCIYNTTYLNVQR (15aa)
- AQLLQGLGFNLTER (14aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- RPTGEVYDIEIDTLETTCHVLDPTPLANCSVR (32aa)
- ENDTHCIDFSYLLYSQK (17aa)
- IAVQFGPGFSWIANFTK (17aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- TAIFPDIIAQGNASIR (16aa)
- TFYWDFYTNR (10aa)
- SIDVSIQNVSVVFK (14aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- DIVEYYNDSNGSHVLQGR (18aa)
- MDLLEPFFSVSQDTNTESTQFQSSELEDSTDYAFLNK (37aa)
- VCSNDNK (7aa)
- TQDEIIFSNSTR (12aa)
- TQSLLIVNNATNVVIK (16aa)
- MLLTFHTDFSNEENGTIMFYK (21aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- TLNQSSDELQLSMGNAMFVK (20aa)
- TLNQSSDELQLSMGN (15aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- RTLNQSSDELQLSMGNAMFVKE (22aa)
- VNNGPLGNPIWNISGDPTR (19aa)
- VDIEDFENNTAYAK (14aa)
- EHEGAIYPDNTTDFQR (16aa)
- GTFTDCALANMTEQIR (16aa)
- QIEEFINQSSPFY (13aa)
- QLEEFLNQSSPF (12aa)
- LCPDCPLLAPLNDSR (15aa)
- RTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (32aa)
- VCQDCPLLAPLNDTR (15aa)
- ETHLETNFTLK (11aa)
- LGSFEGLVNLTFIHLQHNR (19aa)
- GWNWTSGFNK (10aa)
- VYKPSAGNNSLYR (13aa)
- IYIDHNNITR (10aa)
- NGSLFAFR (8aa)
- VVHAVEVALATFNAESNGSYLQLVEISR (28aa)
- MVSHHNLTTGATLINEQWLLTTAK (24aa)
- EHAVFTSNQEEQDPANHTCGVK (22aa)
- QVLFLDTVYGNCSTHFTVK (19aa)
- SWPAVGNCSSALR (13aa)
- SWPAVGNCSSAIR (13aa)
- GNMSGNFTYIIDK (13aa)
- ITYSIVQTNCSK (12aa)
- TPLTANITK (9aa)
- GLTFQQNASSMCGPDQDTAIR (21aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- GITFQQNASSMCVPDQDTAIR (21aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- KNLFLNHSENATAKD (15aa)
- GSLSLTNLSSSMAGVYVCK (19aa)
- LNNLTFLYLDHNALESVPLNLPESLR (26aa)
- KLNNLTFLYLDHNALESVPLNLPESLR (27aa)
- KNVSCYIQNLLLGQEKK (17aa)
- FNHTQTIQQK (10aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- AEFNITIIHPK (11aa)
- VVLHPNYSQVDIGLIK (16aa)
- KVVLHPNYSQVDIGLIKL (18aa)
- VVIHPNYSQVDIGIIK (16aa)
- YFYNGTSMACETFQYGGCMGNGNNFVTEK (29aa)
- ISHNEIADSGIPGNSFNVSSIVEIDISYNK (30aa)
- IGNWSAMPSCK (11aa)
- LGNWSAMPSCK (11aa)
- VINMSYHPR (9aa)
- VVGVPYQGNATALFILPSEGK (21aa)
- MIENGSISFIPTIR (14aa)
- YTGNASALFILPDQDK (16aa)
- KYLGNATAIFFLPDEGKL (18aa)
- DTCPPLMLYNPTTYQMDVNPEGK (23aa)
- LNSSTIK (7aa)
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
- FLLKYNENGTIT (12aa)
- NGTITDAVDCALDPLSE (17aa)
- NSFNISNLLVLHLSHNR (17aa)
- REIRHNSTGCLRM (13aa)
- RHNSTGCLRM (10aa)
- LNAENNATFYFK (12aa)
- EVLSSNVSWR (10aa)
- RTTIVICCSPSSYNESETKS (20aa)
- IIQVVYIHSNNITK (14aa)
- TAGVNTTDK (9aa)
- QDFNITDISLLEHR (14aa)
- MFSQNDTR (8aa)
- INGTQICPN (9aa)
- LHVGNYNGTAGDALR (15aa)
- LAGKPTHVNVSVVMAEVDGTC (21aa)
- YFFNVSDEAAIIEK (14aa)
- NATDNISK (8aa)
- LYLGSNNLTALHPALFQNLSK (21aa)
- NMSNQLGLLAVNQR (14aa)
- VQPFNVTQGK (10aa)
- DASSFIAEWQNITK (14aa)
- LANLTQGEDQYYLR (14aa)
- NILDALMLNTTR (12aa)
- ENLTAPGSDSAVFFEQGTTR (20aa)
- VVNPTQK (7aa)
- DVNYTQIVVDR (11aa)
- SFHNFTLCYIK (11aa)
- CGIVPVIAENYNK (13aa)
- KCGLVPVLAENYNKS (15aa)
- CGLVPVLAENYNK (13aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVKK (33aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- ALPQPQNVTSLLGCTH (16aa)
- AIPQPQNVTSIIGCTH (16aa)
- NGSAAMCHFTTK (12aa)
- TPASDPHGDNLTYSVFYTK (19aa)
- NFTEVHPDYGSHIQALLDK (19aa)
- SYNDSVDPR (9aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- NETHFDAGAK (10aa)
- IHNQIIPNVTTVER (14aa)
- LCNNPTPQFGGK (12aa)
- DQCIVDDITYNVNDTFHK (18aa)
- CQEAINATCK (10aa)
- KCQEAINATCK (11aa)
- AAIPSALDTNSSK (13aa)
- KAAIPSALDTNSSKS (15aa)
- INNLTVSLEMEK (12aa)
- QQQHIFGSNVTDCSGNFCIFR (21aa)
- NVSVDSTHPTK (11aa)
- NISDISENLK (10aa)
- IETILLNGTDR (11aa)
- NNTNNWR (7aa)
- ELHHLQEQNVSNAFLDK (17aa)
- KELHHLQEQNVSNAFLDKG (19aa)
- NESVHPFSPFEVK (13aa)
- NFTVACQHR (9aa)
- RPASNVSASIQR (12aa)
- NSSEFPLFSYNNGVVMTSCR (20aa)
- IPCSQPPQIEHGTINSSR (18aa)
- IIITANVSSENNTPR (15aa)
- ISEENETTCYMGK (13aa)
- ILGTEEPSNVTVK (13aa)
- GNESSLWDCPAR (12aa)
- EDAAVNCTDISVQK (14aa)
- WGHSECGHKEDAAVNCTDISVQK (23aa)
- CIEGSYKGPVKMPSQAPTGNFYPQPLLNSSMCLEDSR (37aa)
- VVNSTTGPGEHIR (13aa)
- NGTHWFVT (8aa)
- EGVFVSNGTHWFVTQR (16aa)
- KNH (3aa)
- KYFKNHTS (8aa)
- NETHNPTVK (9aa)
- NISQDLEK (8aa)
- SLNDSTNR (8aa)
- IPAINQTITEANEK (14aa)
- NNLSLAILTLEMTGDQR (17aa)
- AWGTPCEMCPAVNTSEYK (18aa)
- GNGTAQSADLR (11aa)
- NSTTLVMHMK (10aa)
- NESGIILLGSGGTPAPPR (18aa)
- HVGNQQYNVTYVVKER (16aa)
- TAIFAFNISHVSNK (14aa)
- KPNPVMNGSIK (11aa)
- QNLTVTDR (8aa)
- VGMDGTNK (8aa)
- VEGSHNSTVSLTTK (14aa)
- WEYCNLTR (8aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 2298.1026)
-
Serotransferrin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Eveline (CVCL_A1LI)
- Envelope glycoprotein / Friend murine leukemia virus
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Eveline (CVCL_A1LI)
- Envelope glycoprotein / Friend murine leukemia virus
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
-
Alpha-2-hs-glycoprotein / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
-
Alpha-1-acid glycoprotein / Canis lupus familiaris
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
-
Alpha-1-acid glycoprotein 2 / Homo sapiens
- Undefined site
-
Alpha-1-acid glycoprotein / Bos taurus
- Undefined site
-
Alpha-1-acid glycoprotein / Ovis aries
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Electric Organ (UBERON_0006869)
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Plasma (UBERON_0001969)
- Coagulation factor x / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Zona Pellucida (UBERON_0000086)
-
Zona pellucida sperm-binding protein matrix / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Colon adenocarcinoma (DOID:234)
- Carcinoembryonic antigen glycosylation (2021 - Kolarich D) / Status : Reviewed
- The asparagine-linked oligosaccharides on bovine fetuin. Structural analysis of N-glycanase-released oligosaccharides by 500-megahertz 1H NMR spectroscopy. (1988 - Green E, Adelt G, Baenziger J, Wilson S, Van Halbeek H) / Status : Reviewed
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
Alpha-2-hs-glycoprotein / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
-
Alpha-2-hs-glycoprotein / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
-
Alpha-2-hs-glycoprotein / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977) Mature NK T cell (CL_0000814)
- Blood Serum (UBERON_0001977)
- Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability. (2019 - Patel KR, Nott JD, Barb AW) / Status : Unreviewed
- In-depth analysis of site-specific N-glycosylation in vitronectin from human plasma by tandem mass spectrometry with immunoprecipitation (2014 - Hwang H, Lee JY, Lee HK, Park GW, Jeong HK, Moon MH, Kim JY, Yoo JS.) / Status : Reviewed
- Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
- CD16A-NK08-V/F genotype / Homo sapiens
- CD16A-NK09-V/F genotype / Homo sapiens
- CD16A-NK11-F/F genotype / Homo sapiens
- CD16A-NK12-V/F genotype / Homo sapiens
- CD16A-NK13-V/F genotype / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Vitronectin / Homo sapiens
- FHNESLISSQASSY (14aa)
- P08637 Asn-63     CD16A-NK13-V/F genotype / Homo sapiens
- P08637 Asn-63     CD16A-NK12-V/F genotype / Homo sapiens
- P08637 Asn-63     CD16A-NK08-V/F genotype / Homo sapiens
- P08637 Asn-63     CD16A-NK09-V/F genotype / Homo sapiens
- P08637 Asn-63     CD16A-NK11-F/F genotype / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Plasma (UBERON_0001969)
- Coagulation factor x / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Plasma (UBERON_0001969)
- Coagulation factor x / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Plasma (UBERON_0001969)
- Coagulation factor x / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Milk (UBERON_0001913)
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Butyrophilin subfamily 1 member A1 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Haptoglobin / Homo sapiens
- Kinesin-1 heavy chain / Homo sapiens
- Lactotransferrin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Serotransferrin / Homo sapiens
- RALGFENATQALGRA (15aa)
- KKKEDALNETRE (12aa)
- RTLNQSSDELQLSMGNAMFVKE (22aa)
- RTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (32aa)
- KNLFLNHSENATAKD (15aa)
- KNVSCYIQNLLLGQEKK (17aa)
- KVVLHPNYSQVDIGLIKL (18aa)
- KYLGNATAIFFLPDEGKL (18aa)
- REIRHNSTGCLRM (13aa)
- RHNSTGCLRM (10aa)
- RTTIVICCSPSSYNESETKS (20aa)
- KCGLVPVLAENYNKS (15aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- KAAIPSALDTNSSKS (15aa)
- KELHHLQEQNVSNAFLDKG (19aa)
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
-
- N-Linked / Complex
(avg mass : 2298.1026)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Adipocytes (CL_0000136)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
-
- N-Linked / Complex
(avg mass : 2298.1026)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- NGTITDAVDCALDPLSE (17aa)
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Bone Marrow (UBERON_0002371)
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
-
Alpha-1-acid glycoprotein 1 / Homo sapiens
- Undefined site
-
Serotransferrin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Blood Plasma (UBERON_0001969)
-
Immunoglobulin heavy constant alpha 1 - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant alpha 1 - heavy chain 2 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 1 / Homo sapiens
- Undefined site
-
Immunoglobulin heavy constant epsilon - heavy chain 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Colon (UBERON_0001155)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)[Gal(?1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(?1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)Man(a1-3)[Gal(b1-4)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(?1-?) + NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 2772
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 9470
- N-Linked / Complex / Structure 9546
- N-Linked / Complex / Structure 9565
- N-Linked / Complex / Structure 9636
- N-Linked / Complex / Structure 10039
- N-Linked / Complex / Structure 10436
- N-Linked / Complex / Structure 10655
- N-Linked / Complex / Structure 10700
- N-Linked / Complex / Structure 10929
- N-Linked / Complex / Structure 11250
- Alpha-2-hs-glycoprotein / Bos taurus
- RPTGEVYDIEIDTLETTCHVLDPTPLANCSVR (32aa)
- LCPDCPLLAPLNDSR (15aa)
- VVHAVEVALATFNAESNGSYLQLVEISR (28aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
- Colon (UBERON_0001155)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- Jurkat (CVCL_0065)
- LS174T (CVCL_1384)
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)[Gal(?1-?)GlcNAc(?1-?)]Man(a1-?)[Gal(?1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-6)"
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)Man(a1-3)[Gal(b1-4)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(?1-?) + NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc(a2-3)"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 2772
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 9470
- N-Linked / Complex / Structure 9546
- N-Linked / Complex / Structure 9565
- N-Linked / Complex / Structure 9636
- N-Linked / Complex / Structure 10039
- N-Linked / Complex / Structure 10436
- N-Linked / Complex / Structure 10655
- N-Linked / Complex / Structure 10700
- N-Linked / Complex / Structure 10929
- N-Linked / Complex / Structure 11250
- Cancer, breast (DOID:1612)
- Colon adenocarcinoma (DOID:234)
- COVID-19 (DOID:0080600)
- Prostate cancer (DOID:10283)
- T-cell childhood acute lymphocytic leukemia (DOID:0080145)
- Carcinoembryonic antigen glycosylation (2021 - Kolarich D) / Status : Reviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells. (2019 - Martina Pirro, Esmee Schoof, Sandra J. van Vliet, Yoann Rombouts, Alexandre Stella, Arnoud de Ru, Yassene Mohammed, Manfred Wuhrer, Peter A. van Veelen, Paul J. Hensbergen) / Status : Reviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- ADAM DEC1 / Homo sapiens
- Adenosine deaminase 2 / Homo sapiens
- Adhesion G protein-coupled receptor F5 / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Aminopeptidase n / Homo sapiens
- Angiotensin-converting enzyme / Homo sapiens
- Angiotensinogen / Homo sapiens
- Apolipoprotein (a) / Homo sapiens
- Apolipoprotein B-100 / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Attractin / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Carboxypeptidase N subunit 2 / Homo sapiens
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
- Catalase / Homo sapiens
- CD109 antigen / Homo sapiens
- CD276 antigen / Homo sapiens
- CD44 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Cholesteryl ester transfer protein / Homo sapiens
- Clusterin / Homo sapiens
- Coagulation factor VIII / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement c1r subcomponent / Homo sapiens
- Complement factor h / Homo sapiens
- Contactin-4 / Homo sapiens
- Corticosteroid-binding globulin / Homo sapiens
- Decorin / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens
- Ecto-ADP-ribosyltransferase 4 / Homo sapiens
- Endoplasmic reticulum aminopeptidase 2 / Homo sapiens
- Endothelial cell-selective adhesion molecule / Homo sapiens
- Ephrin-B2 / Homo sapiens
- Epidermal growth factor receptor / Homo sapiens
- Epithelial cell adhesion molecule / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibroblast growth factor receptor 1 / Homo sapiens
- Fibroleukin / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Filamin-B / Homo sapiens
- Folate receptor alpha / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Gamma-glutamyltransferase light chain 1 / Homo sapiens
- Gamma-glutamyltransferase light chain 2 / Homo sapiens
- Gamma-glutamyltranspeptidase 1 / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Hepatocyte growth factor receptor / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 4 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Integrin alpha-2 / Homo sapiens
- Integrin alpha-X / Homo sapiens
- Interferon alpha/beta receptor 2 / Homo sapiens
- Interleukin-6 receptor subunit beta / Homo sapiens
- Kininogen-1 / Homo sapiens
- Laminin subunit alpha-2 / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Low-density lipoprotein receptor-related protein 2 / Homo sapiens
- Lumican / Homo sapiens
- Lymphatic vessel endothelial hyaluronic acid receptor 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Maltase-glucoamylase, intestinal / Homo sapiens
- Microfibril-associated glycoprotein 4 / Homo sapiens
- Mimecan / Homo sapiens
- Multimerin-1 / Homo sapiens
- Myeloperoxidase / Homo sapiens
- Neogenin / Homo sapiens
- Neuron navigator 2 / Homo sapiens
- Neuronal cell adhesion molecule / Homo sapiens
- Plasma serine protease inhibitor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Protein AMBP / Homo sapiens
- Ras-specific guanine nucleotide-releasing factor 1 / Homo sapiens
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Receptor-type tyrosine-protein phosphatase mu / Homo sapiens
- RNA-binding protein 44 / Homo sapiens
- Scavenger receptor cysteine-rich type 1 protein M130 / Homo sapiens
- Secretogranin-3 / Homo sapiens
- Semaphorin-3F / Homo sapiens
- Semaphorin-4D / Homo sapiens
- Serotransferrin / Homo sapiens
- Sparc / Homo sapiens
- Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 / Homo sapiens
- Target of Nesh-SH3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Transmembrane glycoprotein NMB / Homo sapiens
- Transmembrane protein 87A / Homo sapiens
- Trem-like transcript 2 protein / Homo sapiens
- Uromodulin / Homo sapiens
- Vitronectin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- LVPVPITNATLDR (13aa)
- LVPVPITNATLDQITGK (17aa)
- SIVLEPIYWNSSNSK (15aa)
- TAVNCSSDFDACLITK (16aa)
- HLVIHNESTCEQLAK (15aa)
- WQMNFTVR (8aa)
- ANQQLNFTEAK (11aa)
- KANQQINFTEAK (12aa)
- ATGTAHFFNFLLNTTDYR (18aa)
- AFNSTLPTMAQMEK (14aa)
- NTTIFLK (7aa)
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- CIQANYSLMENGK (13aa)
- CIQANYSIMENGK (13aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- SVQEIQATFFYFTPNK (16aa)
- AEMNGSK (7aa)
- SVVAPATDGGLNLTSTFLRK (20aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- NNATVHEQVGGPSLTSDLQAQSK (23aa)
- VVNITMVALK (10aa)
- QNQCFYNSSYLNVQR (15aa)
- QDQCIYNTTYINVQR (15aa)
- QDQCIYNTTYLNVQR (15aa)
- AQLLQGLGFNLTER (14aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- ENDTHCIDFSYLLYSQK (17aa)
- IAVQFGPGFSWIANFTK (17aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- TAIFPDIIAQGNASIR (16aa)
- TFYWDFYTNR (10aa)
- SIDVSIQNVSVVFK (14aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- DIVEYYNDSNGSHVLQGR (18aa)
- MDLLEPFFSVSQDTNTESTQFQSSELEDSTDYAFLNK (37aa)
- VCSNDNK (7aa)
- TQDEIIFSNSTR (12aa)
- MLLTFHTDFSNEENGTIMFYK (21aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- TLNQSSDELQLSMGNAMFVK (20aa)
- TLNQSSDELQLSMGN (15aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- VNNGPLGNPIWNISGDPTR (19aa)
- VDIEDFENNTAYAK (14aa)
- EHEGAIYPDNTTDFQR (16aa)
- GTFTDCALANMTEQIR (16aa)
- QIEEFINQSSPFY (13aa)
- QLEEFLNQSSPF (12aa)
- VCQDCPLLAPLNDTR (15aa)
- ETHLETNFTLK (11aa)
- LGSFEGLVNLTFIHLQHNR (19aa)
- GWNWTSGFNK (10aa)
- VYKPSAGNNSLYR (13aa)
- IYIDHNNITR (10aa)
- NGSLFAFR (8aa)
- MVSHHNLTTGATLINEQWLLTTAK (24aa)
- EHAVFTSNQEEQDPANHTCGVK (22aa)
- QVLFLDTVYGNCSTHFTVK (19aa)
- SWPAVGNCSSALR (13aa)
- SWPAVGNCSSAIR (13aa)
- GNMSGNFTYIIDK (13aa)
- ITYSIVQTNCSK (12aa)
- TPLTANITK (9aa)
- GLTFQQNASSMCGPDQDTAIR (21aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- GITFQQNASSMCVPDQDTAIR (21aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- GSLSLTNLSSSMAGVYVCK (19aa)
- LNNLTFLYLDHNALESVPLNLPESLR (26aa)
- KLNNLTFLYLDHNALESVPLNLPESLR (27aa)
- FNHTQTIQQK (10aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- AEFNITIIHPK (11aa)
- VVLHPNYSQVDIGLIK (16aa)
- VVIHPNYSQVDIGIIK (16aa)
- YFYNGTSMACETFQYGGCMGNGNNFVTEK (29aa)
- ISHNEIADSGIPGNSFNVSSIVEIDISYNK (30aa)
- IGNWSAMPSCK (11aa)
- LGNWSAMPSCK (11aa)
- VINMSYHPR (9aa)
- VVGVPYQGNATALFILPSEGK (21aa)
- MIENGSISFIPTIR (14aa)
- YTGNASALFILPDQDK (16aa)
- DTCPPLMLYNPTTYQMDVNPEGK (23aa)
- LNSSTIK (7aa)
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
- FLLKYNENGTIT (12aa)
- NSFNISNLLVLHLSHNR (17aa)
- LNAENNATFYFK (12aa)
- EVLSSNVSWR (10aa)
- IIQVVYIHSNNITK (14aa)
- TAGVNTTDK (9aa)
- QDFNITDISLLEHR (14aa)
- MFSQNDTR (8aa)
- INGTQICPN (9aa)
- LHVGNYNGTAGDALR (15aa)
- LAGKPTHVNVSVVMAEVDGTC (21aa)
- YFFNVSDEAAIIEK (14aa)
- NATDNISK (8aa)
- LYLGSNNLTALHPALFQNLSK (21aa)
- NMSNQLGLLAVNQR (14aa)
- VQPFNVTQGK (10aa)
- DASSFIAEWQNITK (14aa)
- LANLTQGEDQYYLR (14aa)
- NILDALMLNTTR (12aa)
- ENLTAPGSDSAVFFEQGTTR (20aa)
- VVNPTQK (7aa)
- DVNYTQIVVDR (11aa)
- SFHNFTLCYIK (11aa)
- CGIVPVIAENYNK (13aa)
- CGLVPVLAENYNK (13aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVKK (33aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- ALPQPQNVTSLLGCTH (16aa)
- AIPQPQNVTSIIGCTH (16aa)
- NGSAAMCHFTTK (12aa)
- TPASDPHGDNLTYSVFYTK (19aa)
- NFTEVHPDYGSHIQALLDK (19aa)
- SYNDSVDPR (9aa)
- NETHFDAGAK (10aa)
- IHNQIIPNVTTVER (14aa)
- LCNNPTPQFGGK (12aa)
- DQCIVDDITYNVNDTFHK (18aa)
- CQEAINATCK (10aa)
- KCQEAINATCK (11aa)
- AAIPSALDTNSSK (13aa)
- INNLTVSLEMEK (12aa)
- QQQHIFGSNVTDCSGNFCIFR (21aa)
- NVSVDSTHPTK (11aa)
- NISDISENLK (10aa)
- IETILLNGTDR (11aa)
- NNTNNWR (7aa)
- ELHHLQEQNVSNAFLDK (17aa)
- NESVHPFSPFEVK (13aa)
- NFTVACQHR (9aa)
- RPASNVSASIQR (12aa)
- NSSEFPLFSYNNGVVMTSCR (20aa)
- IPCSQPPQIEHGTINSSR (18aa)
- IIITANVSSENNTPR (15aa)
- ISEENETTCYMGK (13aa)
- ILGTEEPSNVTVK (13aa)
- GNESSLWDCPAR (12aa)
- EDAAVNCTDISVQK (14aa)
- WGHSECGHKEDAAVNCTDISVQK (23aa)
- CIEGSYKGPVKMPSQAPTGNFYPQPLLNSSMCLEDSR (37aa)
- VVNSTTGPGEHIR (13aa)
- NGTHWFVT (8aa)
- EGVFVSNGTHWFVTQR (16aa)
- KNH (3aa)
- KYFKNHTS (8aa)
- NETHNPTVK (9aa)
- NISQDLEK (8aa)
- SLNDSTNR (8aa)
- IPAINQTITEANEK (14aa)
- NNLSLAILTLEMTGDQR (17aa)
- AWGTPCEMCPAVNTSEYK (18aa)
- GNGTAQSADLR (11aa)
- NSTTLVMHMK (10aa)
- NESGIILLGSGGTPAPPR (18aa)
- HVGNQQYNVTYVVKER (16aa)
- TAIFAFNISHVSNK (14aa)
- KPNPVMNGSIK (11aa)
- QNLTVTDR (8aa)
- VGMDGTNK (8aa)
- VEGSHNSTVSLTTK (14aa)
- WEYCNLTR (8aa)
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reference
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2298.1026)